Clinical Trial Explores Azithromycin, Hydroxychloroquine Combo as COVID-19 Treatment

Rutgers Cancer Institute of New Jersey will be conducting a clinical trial assessing whether azithromycin combined with hydroxychloroquine is better than hydroxychloroquine alone as a potential treatment for patients diagnosed with COVID-19.

Source: CancerNetwork - April 11, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news